Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Eledon Pharmaceuticals, Inc. (ELDN) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-3.93M |
|
-- |
|
-- |
|
$21.67M |
|
$-21.67M |
|
$17.74M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-21.67M |
|
$-21.67M |
|
114.72M |
|
114.72M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$73.71M |
|
-- |
|
$32.93M |
|
$106.64M |
|
$11.70M |
|
-- |
|
$25.12M |
|
$36.83M |
|
$30.80M |
|
$69.81M |
|
$69.81M |
|
81.44M |
|
| Cash Flow Statement Financials | |
$-64.27M |
|
$48.52M |
|
$-0.18M |
|
$22.81M |
|
$6.88M |
|
$-15.93M |
|
$7.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.30 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-64.27M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.77% |
|
-5.63% |
|
-3.69% |
|
-5.63% |
|
$0.86 |
|
$-0.56 |
|
$-0.56 |
|